While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
A total of 188 biopsy-proven chronic hepatitis B patients were followed for a mean ... of porto-periportal activity and fibrosis stage, although the differences were not significant (data not ...
bringing us closer to a functional cure for chronic hepatitis B. This research not only advances our understanding of HBV biology but also sets the stage for the next generation of therapeutic ...
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil ...
ADULT patients coming in for Emergency Department treatment needing blood tests are now automatically being screened for ...
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...